Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles G Drake

Showing results (21-30 of 266) with videos related to

Pageof 27
Sort By:
Journal for Immunotherapy of Cancer|May 16, 2014
Primer on tumor immunology and cancer immunotherapyTimothy J Harris, Charles G Drake
Current Opinion in Urology|February 14, 2012
Current status of immunological approaches for the treatment of prostate cancerCharles G Drake, Emmanuel S Antonarakis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2018
The Immunobiology of Kidney CancerCharles G Drake, Mark N Stein
Cold Spring Harbor Perspectives in Medicine|September 12, 2018
Immunotherapy for Prostate CancerNicholas J Venturini, Charles G Drake
Journal of Leukocyte Biology|May 28, 2017
Myeloid-derived cells in prostate cancer progression: phenotype and prospective therapiesZoila Lopez-Bujanda, Charles G Drake
Cancer Journal (Sudbury, Mass.)|January 24, 2018
Blocking PD-1/PD-L1 in Genitourinary Malignancies: To Immunity and BeyondMatthew C Dallos, Charles G Drake
Surgical Oncology Clinics of North America|November 21, 2007
Current immunotherapeutic strategies in prostate cancerJoseph F Grosso, Charles G Drake
Journal for Immunotherapy of Cancer|November 22, 2017
Biomarkers for immunotherapy in bladder cancer: a moving targetDavid H Aggen, Charles G Drake
Current Topics in Microbiology and Immunology|November 19, 2010
LAG-3 in Cancer ImmunotherapyMonica V Goldberg, Charles G Drake
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 9, 2011
Ipilimumab: an anti-CTLA-4 antibody for metastatic melanomaEvan J Lipson, Charles G Drake
Pageof 27

Showing results (21-30 of 266) with videos related to

Sort By:
Pageof 27
Journal for Immunotherapy of Cancer|May 16, 2014
Primer on tumor immunology and cancer immunotherapyTimothy J Harris, Charles G Drake
Current Opinion in Urology|February 14, 2012
Current status of immunological approaches for the treatment of prostate cancerCharles G Drake, Emmanuel S Antonarakis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2018
The Immunobiology of Kidney CancerCharles G Drake, Mark N Stein
Cold Spring Harbor Perspectives in Medicine|September 12, 2018
Immunotherapy for Prostate CancerNicholas J Venturini, Charles G Drake
Journal of Leukocyte Biology|May 28, 2017
Myeloid-derived cells in prostate cancer progression: phenotype and prospective therapiesZoila Lopez-Bujanda, Charles G Drake
Cancer Journal (Sudbury, Mass.)|January 24, 2018
Blocking PD-1/PD-L1 in Genitourinary Malignancies: To Immunity and BeyondMatthew C Dallos, Charles G Drake
Surgical Oncology Clinics of North America|November 21, 2007
Current immunotherapeutic strategies in prostate cancerJoseph F Grosso, Charles G Drake
Journal for Immunotherapy of Cancer|November 22, 2017
Biomarkers for immunotherapy in bladder cancer: a moving targetDavid H Aggen, Charles G Drake
Current Topics in Microbiology and Immunology|November 19, 2010
LAG-3 in Cancer ImmunotherapyMonica V Goldberg, Charles G Drake
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 9, 2011
Ipilimumab: an anti-CTLA-4 antibody for metastatic melanomaEvan J Lipson, Charles G Drake
Pageof 27